Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2023Ophthalmology and TherapyOpen Access

Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSophie J. BakriMayo Clinic in ArizonaMDMarie‐Noëlle DelyferUniversité de BordeauxJGJakob GrauslundUniversity of Southern Denmark

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bakri et al. (2023) studied this question.

synapsesocial.com/papers/6a6277445aedc878c5f59239https://doi.org/10.1007/s40123-023-00750-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins2012 · 272 citations
  2. 2Graphical Depiction of Longitudinal Study Designs in Health Care Databases2019 · 280 citations
  3. 3COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE2017 · 158 citations
  4. 4Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients2017 · 167 citations
  5. 5Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections1998 · 6,334 citations